Radiomics: Definition and clinical development

被引：18

作者：

Bourgier, C. ^{[1
,2
,3
,4
]}

Colinge, J. ^{[1
,2
,3
]}

Ailleres, N. ^{[4
]}

Fenoglietto, P. ^{[4
]}

Brengues, M. ^{[1
,2
,3
,4
]}

Pelegrin, A. ^{[4
]}

Azria, D. ^{[1
,2
,3
,4
]}

机构：

[1] IRCM, 208 Rue Apothicaires, F-34298 Montpellier 05, France

[2] Inserm U896, F-34298 Montpellier 05, France

[3] Univ Montpellier I, F-34298 Montpellier 05, France

[4] Inst Reg Canc Montpellier ICM, Pole Radiotherapie Oncol, F-34298 Montpellier 05, France

来源：

CANCER RADIOTHERAPIE | 2015年 / 19卷 / 6-7期

关键词：

Radiomics; Genomic; Proteomic; GROWTH-FACTOR-BETA; NORMAL TISSUE RADIOSENSITIVITY; INDUCED LUNG TOXICITY; PROTEOMIC ANALYSIS; CELL CARCINOMA; RADIOTHERAPY; CANCER; EXPRESSION; PREDICTION; IDENTIFY;

D O I：

10.1016/j.canrad.2015.06.008

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

The ultimate goal in radiation oncology is to offer a personalized treatment to all patients indicated for radiotherapy. Radiomics is a tool that reinforces a deep analysis of tumors at the molecular aspect taking into account intrinsic susceptibility in a long-term follow-up. Radiomics allow qualitative and quantitative performance analyses with high throughput extraction of numeric radiologic data to obtain predictive or prognostic information from patients treated for cancer. A second approach is to define biological or constitutional that could change the practice. This technique included normal tissue individual susceptibility but also potential response of tumors under ionizing radiation treatment. These "omics" are biological and technical techniques leading to simultaneous novel identification and exploration a set of genes, lipids, proteins. (C) 2015 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.

引用

页码：532 / 537

页数：6

共 42 条

[1]

Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach [J].

Aerts, Hugo J. W. L. ;

Velazquez, Emmanuel Rios ;

Leijenaar, Ralph T. H. ;

Parmar, Chintan ;

Grossmann, Patrick ;

Cavalho, Sara ;

Bussink, Johan ;

Monshouwer, Rene ;

Haibe-Kains, Benjamin ;

Rietveld, Derek ;

Hoebers, Frank ;

Rietbergen, Michelle M. ;

Leemans, C. Rene ;

Dekker, Andre ;

Quackenbush, John ;

Gillies, Robert J. ;

Lambin, Philippe .

NATURE COMMUNICATIONS, 2014, 5

[2]

Radioresistance-related proteins in rectal cancer [J].

Allal, AS ;

Kähne, T ;

Reverdin, AK ;

Lippert, H ;

Schlegel, W ;

Reymond, MA .

PROTEOMICS, 2004, 4 (08) :2261-2269

[3]

Genetic markers for prediction of normal tissue toxicity after radiotherapy [J].

Alsner, Jan ;

Andreassen, Christian Nicolaj ;

Overgaard, Jens .

SEMINARS IN RADIATION ONCOLOGY, 2008, 18 (02) :126-135

[4]

Will SNPs be useful predictors of normal tissue radiosensitivity in the future? [J].

Andreassen, Christian Nicolaj ;

Dikomey, Ekkehard ;

Parliament, Matthew ;

West, Catharine Mary Louise .

RADIOTHERAPY AND ONCOLOGY, 2012, 105 (03) :283-288

[5]

Searching for genetic determinants of normal tissue radiosensitivity - Are we on the right track? [J].

Andreassen, Christian Nicolaj .

RADIOTHERAPY AND ONCOLOGY, 2010, 97 (01) :1-8

[6]

Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis [J].

Anscher, MS ;

Kong, FM ;

Marks, LB ;

Bentel, GC ;

Jirtle, RL .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (02) :253-258

[7]

CHANGES IN PLASMA TGF-BETA LEVELS DURING PULMONARY RADIOTHERAPY AS A PREDICTOR OF THE RISK OF DEVELOPING RADIATION PNEUMONITIS [J].

ANSCHER, MS ;

MURASE, T ;

PRESCOTT, DM ;

MARKS, LB ;

REISENBICHLER, H ;

BENTEL, GC ;

SPENCER, D ;

SHEROUSE, G ;

JIRTLE, RL .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 30 (03) :671-676

[8]

Comparative proteomic analysis of radiation-induced changes in mouse lung: Fibrosis-sensitive and -resistant strains [J].

Ao, Xiaoping ;

Lubman, David M. ;

Davis, Mary A. ;

Xing, Xianying ;

Kong, Feng-Ming ;

Lawrence, Theodore S. ;

Zhang, Ming .

RADIATION RESEARCH, 2008, 169 (04) :417-425

[9]

Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial [J].

Azria, David ;

Belkacemi, Yazid ;

Romieu, Gilles ;

Gourgou, Sophie ;

Gutowski, Marian ;

Zaman, Khalil ;

Moscardo, Carmen Llacer ;

Lemanski, Claire ;

Coelho, Michael ;

Rosenstein, Barry ;

Fenoglietto, Pascal ;

Crompton, Nigel E. A. ;

Ozsahin, Mahmut .

LANCET ONCOLOGY, 2010, 11 (03) :258-265

[10]

Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity [J].

Barnett, Gillian C. ;

Elliott, Rebecca M. ;

Alsner, Jan ;

Andreassen, Christian N. ;

Abdelhay, Osama ;

Burnet, Neil G. ;

Chang-Claude, Jenny ;

Coles, Charlotte. E. ;

Gutierrez-Enriquez, Sara ;

Fuentes-Raspall, Maria J. ;

Alonso-Munoz, Maria C. ;

Kerns, Sarah ;

Raabe, Annette ;

Symonds, R. Paul ;

Seibold, Petra ;

Talbot, Chris J. ;

Wenz, Frederik ;

Wilkinson, Jennifer ;

Yarnold, John ;

Dunning, Alison M. ;

Rosenstein, Barry S. ;

West, Catharine M. L. ;

Bentzen, Soren M. .

RADIOTHERAPY AND ONCOLOGY, 2012, 105 (03) :289-295

← 1 2 3 4 5 →